Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II booster study of new Infanrix Hexa formulations in previously primed toddlers
2011-000876-33Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2011
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, double-blind trial of pertussis filamentous haemagglutinin and pneumococcal 13-valent conjugate vaccine in diphtheria, Tetanus, pertussis and 4 more (3 arms), sponsored by GSK. Started Jul 2011; status: completed.
02
Drugs
pertussis filamentous haemagglutininpneumococcal 13-valent conjugate vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on 2011-000876-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000876-33.